Headache attributed to masticatory myofascial pain: impact on facial pain and pressure pain threshold

Summary There is no clear evidence on how a headache attributed to temporomandibular disorder (TMD) can hinder the improvement of facial pain and masticatory muscle pain. The aim of this study was to measure the impact of a TMD‐attributed headache on masticatory myofascial (MMF) pain management. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oral rehabilitation 2016-03, Vol.43 (3), p.161-168
Hauptverfasser: Costa, Y. M., Porporatti, A. L., Stuginski-Barbosa, J., Bonjardim, L. R., Speciali, J. G., Conti, P. C. R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary There is no clear evidence on how a headache attributed to temporomandibular disorder (TMD) can hinder the improvement of facial pain and masticatory muscle pain. The aim of this study was to measure the impact of a TMD‐attributed headache on masticatory myofascial (MMF) pain management. The sample was comprised of adults with MMF pain measured according to the revised research diagnostic criteria for temporomandibular disorders (RDC/TMD) and additionally diagnosed with (Group 1, n = 17) or without (Group 2, n = 20) a TMD‐attributed headache. Both groups received instructions on how to implement behavioural changes and use a stabilisation appliance for 5 months. The reported facial pain intensity (visual analogue scale – VAS) and pressure pain threshold (PPT – kgf cm−2) of the anterior temporalis, masseter and right forearm were measured at three assessment time points. Two‐way anova was applied to the data, considering a 5% significance level. All groups had a reduction in their reported facial pain intensity (P < 0·001). Mean and standard deviation (SD) PPT values, from 1·33 (0·54) to 1·96 (1·06) kgf cm−2 for the anterior temporalis in Group 1 (P = 0·016), and from 1·27 (0·35) to 1·72 (0·60) kgf cm−2 for the masseter in Group 2 (P = 0·013), had significant improvement considering baseline versus the 5th‐month assessment. However, no differences between the groups were found (P > 0·100). A TMD‐attributed headache in patients with MMF pain does not negatively impact pain management, but does change the pattern for muscle pain improvement.
ISSN:0305-182X
1365-2842
DOI:10.1111/joor.12357